AbbVie

AbbVie is a publicly listed biopharmaceutical company based in the United States that was created in 2013. It began as a spin-off from Abbott Laboratories.

The company specializes in the research, production, and development of pharmaceuticals in the fields of HIV, hepatitis C, autoimmune diseases, and some other diseases. The company has 7 drug production facilities and distributes to more than 170 countries around the world.

With more than 47,000 professionals and the successful acquisition of Allergan (an American pharmaceutical company) in May 2019, AbbVie strengthens the company's position in several therapeutic areas including immunology, oncology, and neuroscience.

In 2019, the company's revenue increased 2% with significant achievements in the medical and philanthropic side.

Some products stand out: Norvir & Kaletra HIV drug; AndroGel low testosterone drug; TriCor, Niaspan & Trilipix high blood cholesterol medicine; Humira for the treatment of Crohn's disease and arthritis; Imbruvica & Venclexta leukemia medicine,...

• Headquarter: Lake Bluff, Illinois, United States
• Founded: 2013
• Revenue: $45.8 billion (2020)
• Website: http://abbvie.com/